Shaoxiang Weng

机构：Xiamen University Malaysia

发表论文 14 篇 · 总被引 213 次 · h-index 9

代表论文

• The Rho kinase inhibitor, fasudil, ameliorates diabetes-induced cardiac dysfunction by improving calcium clearance and actin remodeling (2016 · Journal of Molecular Medicine · 被引 39)
• Safety and efficacy of autologous thymosin β4 pre-treated endothelial progenitor cell transplantation in patients with acute ST segment elevation myocardial infarction: A pilot study (2016 · Cytotherapy · 被引 32)
• Advanced Glycation End Product (AGE)-AGE Receptor (RAGE) System Upregulated Connexin43 Expression in Rat Cardiomyocytes via PKC and Erk MAPK Pathways (2013 · International Journal of Molecular Sciences · 被引 32)
• Predicting the Prognosis of Patients in the Coronary Care Unit: A Novel Multi-Category Machine Learning Model Using XGBoost (2022 · Frontiers in Cardiovascular Medicine · 被引 28)
• Protective effect of erythropoietin on myocardial infarction in rats by inhibition of caspase-12 expression (2011 · Experimental and Therapeutic Medicine · 被引 17)
• NADPH oxidase activation played a critical role in the oxidative stress process in stable coronary artery disease. (2016 · PubMed · 被引 15)